In 2025, Santen Pharmaceutical conducted an environmental assessment and disclosed corporate waste management data in accordance with recognized sustainability reporting standards.The company provided a breakdown of its waste by type (hazardous vs non-hazardous) and treatment method (recovery vs disposal), enabling greater transparency into its waste handling and environmental practices.
| Metric (tonnes) | 2025 | 2024 | 2023 | 2022-2019 |
|---|---|---|---|---|
Total Waste Generated | 3,426a | 3,280a | 2,724a | |
Total Waste Recovered | 2,586a | 2,548a | 2,074a | |
Total Hazardous Waste Generated | 204a | 146a | 193a | |
Non-Hazardous Waste Disposed | N/A | N/A | N/A |
You are welcome to quote or reference individual data points from this page, provided you include the following attribution with a visible, clickable link to this page: "Source: Tracenable, the global reference for ESG data"
Bulk collection, scraping, resale, or redistribution of data across multiple company profiles is not permitted without our prior written permission. For more information, see our General Terms and Conditions.
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform.
In 2025, Santen Pharmaceutical generated a total of 3,426metric tonnes of waste.a
Of this amount, 75.48% of Santen Pharmaceutical's total waste generated was recovered through methods such as recycling, reuse, or composting, while 24.52% was disposed of through landfilling, incineration, or combustion.a
In 2025, Santen Pharmaceutical reported a total waste generation of 3,426 metric tonnes, of which 75.48% was recovered through recycling, reuse, or composting.This high recovery rate suggests that Santen Pharmaceutical has implemented strong circular economy practices and actively prioritizes sustainable waste management.a
Since 2022, Santen Pharmaceutical's total waste generation increased by 13.26%, including a 4.45%increase in 2025, indicating a persistent upward trend that may reflect scaling operations, inefficiencies in resource use, or a lack of effective waste minimization practices.a
Over the same period, Santen Pharmaceutical's waste recovery rate declined by 11.33%, with a further 2.83% drop in 2025, underscoring a weakening in waste diversion performance and a potential drift away from circular waste strategies.a
Overall, Santen Pharmaceutical is generating more waste while simultaneously backsliding on recovery efforts, both in the short and long term. This dual negative trend raises concerns about the company’s waste management priorities and its alignment with sustainability goals.